O’Leary, Ben http://orcid.org/0000-0002-1092-9169
Article History
First Online: 23 November 2022
Competing interests
: B.O’L. has received institutional research funding through the Institute of Cancer Research from Pfizer and has been a consultant to Merck Serono.